A randomized controlled trial comparing efficacy of early video capsule endoscopy with standard of care in the approach to nonhematemesis GI bleeding (with videos).


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 04 2018
accepted: 09 06 2018
pubmed: 24 6 2018
medline: 12 4 2019
entrez: 24 6 2018
Statut: ppublish

Résumé

Patients presenting with nonhematemesis GI bleeding (NHGIB) represent a diagnostic challenge for physicians. We performed a randomized controlled trial to assess the benefits of deployment of a video capsule soon after admission in the management of patients presenting with melena, hematochezia, or severe anemia compared with standard of care management. Patients admitted with NHGIB were randomized and placed into 1 of 2 study groups. In the experimental group, patients ingested a video capsule soon after admission to the hospital. These patients had further endoscopic workup based on the findings from the capsule. Patients in the control group underwent endoscopic evaluation (ie, upper endoscopy, capsule endoscopy, and/or colonoscopy) to identify the source of bleeding as directed by the attending gastroenterologist's interpretation of their clinical presentation. The primary endpoint for this study was the rate of localization of bleeding during hospitalization. Eighty-seven patients were included in this study: 45 randomized to the standard of care arm and 42 to the early capsule arm. A bleeding source was localized in 64.3% of the patients in the early capsule arm and in 31.1% of the patients in the standard of care arm (P < .01). The likelihood of endoscopic localization of bleeding over time was greater for patients receiving early capsule endoscopy compared with those in the standard of care arm (adjusted hazard ratio, 2.77; 95% confidence interval, 1.36-5.64). For patients admitted to the hospital for NHGIB, early capsule endoscopy is a safe and effective alternative for the detection of the source of bleeding. (Clinical trial registration number: NCT02442830.).

Sections du résumé

BACKGROUND AND AIMS
Patients presenting with nonhematemesis GI bleeding (NHGIB) represent a diagnostic challenge for physicians. We performed a randomized controlled trial to assess the benefits of deployment of a video capsule soon after admission in the management of patients presenting with melena, hematochezia, or severe anemia compared with standard of care management.
METHODS
Patients admitted with NHGIB were randomized and placed into 1 of 2 study groups. In the experimental group, patients ingested a video capsule soon after admission to the hospital. These patients had further endoscopic workup based on the findings from the capsule. Patients in the control group underwent endoscopic evaluation (ie, upper endoscopy, capsule endoscopy, and/or colonoscopy) to identify the source of bleeding as directed by the attending gastroenterologist's interpretation of their clinical presentation. The primary endpoint for this study was the rate of localization of bleeding during hospitalization.
RESULTS
Eighty-seven patients were included in this study: 45 randomized to the standard of care arm and 42 to the early capsule arm. A bleeding source was localized in 64.3% of the patients in the early capsule arm and in 31.1% of the patients in the standard of care arm (P < .01). The likelihood of endoscopic localization of bleeding over time was greater for patients receiving early capsule endoscopy compared with those in the standard of care arm (adjusted hazard ratio, 2.77; 95% confidence interval, 1.36-5.64).
CONCLUSIONS
For patients admitted to the hospital for NHGIB, early capsule endoscopy is a safe and effective alternative for the detection of the source of bleeding. (Clinical trial registration number: NCT02442830.).

Identifiants

pubmed: 29935143
pii: S0016-5107(18)32778-0
doi: 10.1016/j.gie.2018.06.016
pmc: PMC6501558
mid: NIHMS1017791
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02442830']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-43.e4

Subventions

Organisme : NIDDK NIH HHS
ID : T32 DK007038
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2000 Jan 13;342(2):78-82
pubmed: 10631275
Nature. 2000 May 25;405(6785):417
pubmed: 10839527
Lancet. 2000 Oct 14;356(9238):1318-21
pubmed: 11073021
Value Health. 2008 Jan-Feb;11(1):1-3
pubmed: 18237354
Best Pract Res Clin Gastroenterol. 2008;22(2):313-28
pubmed: 18346686
Gastrointest Endosc. 2009 Apr;69(4):786-99
pubmed: 19152905
Ann Intern Med. 2010 Jan 19;152(2):101-13
pubmed: 20083829
J Gastroenterol Hepatol. 2011 Aug;26(8):1270-4
pubmed: 21443670
Am J Gastroenterol. 2012 Mar;107(3):345-60; quiz 361
pubmed: 22310222
Gastrointest Endosc. 2012 Jun;75(6):1132-8
pubmed: 22624808
Dig Liver Dis. 2013 Mar;45(3):179-85
pubmed: 22921043
World J Gastroenterol. 2012 Nov 21;18(43):6235-9
pubmed: 23180943
Gastrointest Endosc. 2013 May;77(5):761-6
pubmed: 23375526
Cochrane Database Syst Rev. 2014 Oct 13;(10):CD005584
pubmed: 25308912
Gastrointest Endosc. 2015 Apr;81(4):889-95
pubmed: 25432532
Gastroenterol Clin North Am. 2014 Dec;43(4):643-63
pubmed: 25440917
Gastrointest Endosc. 2015 Apr;81(4):896-7
pubmed: 25805463
Am J Gastroenterol. 2015 Sep;110(9):1265-87; quiz 1288
pubmed: 26303132
Endoscopy. 2015 Oct;47(10):a1-46
pubmed: 26417980
Clin Gastroenterol Hepatol. 2016 Apr;14(4):558-64
pubmed: 26492844
Gastrointest Endosc. 2016 Dec;84(6):907-913
pubmed: 27156655
Dig Dis Sci. 2016 Sep;61(9):2732-40
pubmed: 27286877
J Clin Gastroenterol. 2017 Sep;51(8):720-727
pubmed: 27557115
Gastrointest Endosc. 2017 May;85(5):945-952.e1
pubmed: 27693643
BMJ. 2017 Jan 4;356:i6432
pubmed: 28053181
Lancet. 1974 Aug 17;2(7877):394-7
pubmed: 4136718
Am J Gastroenterol. 1995 Feb;90(2):206-10
pubmed: 7847286
Am J Gastroenterol. 1997 Mar;92(3):419-24
pubmed: 9068461

Auteurs

Neil B Marya (NB)

Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, California, USA.

Salmaan Jawaid (S)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Anne Foley (A)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Samuel Han (S)

University of Colorado, Aurora, Colorado, USA.

Krunal Patel (K)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Louise Maranda (L)

Department of Quantitative Health Sciences, University of Massachusetts, Worcester, Massachusetts, USA.

Daniel Kaufman (D)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Kanishka Bhattacharya (K)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Christopher Marshall (C)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Joseph Tennyson (J)

Department of Emergency Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

David R Cave (DR)

Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH